TOPIC

/ company

GlaxoSmithKline

The London-based multinational drugmaker, also known as GSK, supplies key products such as vaccines in China, as well as drugs for lung disease and cancer. In 2013, the company was targeted by Chinese authorities over alleged corruption, price-fixing and quality controls.

Chairman / President

Jonathan Symonds

CEO / Managing Director

Dame Emma Natasha Walmsley

CFO / Finance Director

Julie Brown

Industry

Pharmaceutical

Website

gsk.com

Headquarters address

79 New Oxford Street, London, WC1A 1DG, United Kingdom

Stock Code

NYSE:GSK
LSE:GSK

Year founded

2000

GSK has agreed a deal worth up to US$750 million to license a T-cell engager from a Chinese biotechnology firm. Photo: Reuters

Biomedicine: Companies

GSK’s US$750 million cancer drug deal highlights China’s rise as biotech player

The acquisition is the latest in a string of major licensing deals involving Chinese biotechnology firms.

16 Sep 2026 - 5:14PM

Greater Bay Area

Data from Greater Bay Area residents to help improve healthcare policy: GSK

14 Sep 2026 - 3:13PM

Hong Kong economy

Which global firms are being attracted by Hong Kong’s strategic enterprise scheme?

21 Apr 2026 - 9:30AM

China’s crackdowns

China charges former AstraZeneca executive – a sign of the times?

Foreign drug makers face pressure in the Chinese market, from tighter regulatory oversight to growing local competition.

13 Feb 2026 - 8:00PM

In January, AstraZeneca announced plans to invest US$15 billion in China, its second-largest market. Photo: Shutterstock

Made in China 2025

Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025

Chinese drug makers signed 157 out-licensing deals with global pharmaceutical firms last year versus 94 a year earlier.

8 Jan 2026 - 8:30AM

China economy

Opinion | How China engineered the rapid rise of its drug innovation industry

A market once dominated by generics is now an AI-powered pharmaceutical hub drawing billion-dollar investments from the likes of Pfizer and GSK.

4 Dec 2025 - 10:51AMvideocam

Hong Kong economy

Letters | How Hong Kong can help Chinese drug makers go global

Readers discuss opportunities from medical innovation, tech standards in Hong Kong, and how to stop people treating corals like inanimate objects.

27 Oct 2025 - 11:30AM

A view of the Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone on April 24. Photo: Edmond So

Hong Kong economy

Digital IP protector from US among 18 firms expanding in Hong Kong under OASES

Vobile among 18 new strategic enterprises that OASES has brought to city.

9 Oct 2025 - 10:22PM

Hong Kong healthcare and hospitals

Hong Kong to launch collaborative study on long-term effects of shingles vaccine

Study by clinical trial institute, University of Hong Kong and drug giant GlaxoSmithKline will assess potential of heart and dementia protection.

9 Sep 2025 - 5:55PM

Biomedicine: Companies

China’s Jiangsu Hengrui signs licensing deal with Braveheart Bio for heart drug

The licensing deal for the HRS-1893 innovative drug could fetch as much as US$1.01 billion in milestone payments.

5 Sep 2025 - 4:20PM

The headquarters of Jiangsu Hengrui Pharmaceutical in Lianyungang Economic and Technological Development Zone, in Jiangsu province. Photo: Costfoto/Future Publishing via Getty Images

Biomedicine: Companies

Chinese pharma firms Hengrui, Hansoh expected to post strong first-half profits

Novel drug roll-outs and revenue from licensing buoy results.

18 Aug 2025 - 7:30AM

Workers inside Hansoh Pharmaceutical. Photo: Handout

Biomedicine: Companies

Opinion | Biotech successes helping Chinese intellectual property go global

After years of buying licences for foreign-made medicines, Chinese biotech firms are now profiting handsomely from their own innovations.

5 Aug 2025 - 5:30AMvideocam

Biomedicine: Companies

GSK to pay Hengrui US$12.5 billion for global rights to 12 drug projects

The deal would give GSK the rights to develop the drug for HRS-9821 and 11 preclinical programmes owned by Jiangsu Hengrui Pharmaceuticals.

28 Jul 2025 - 9:37PM

Indonesia

Is Indonesia a ‘guinea pig’ in Bill Gates-backed TB vaccine trial?

The controversy began after President Prabowo Subianto said that Bill Gates was developing a tuberculosis vaccine to be tested in Indonesia.

15 May 2025 - 6:08PM

Bill Gates speaks at a Save the Children event on vaccine equity in Germany last year. Photo: AP

United States

FDA approves GSK vaccine to combat meningococcal infections

Meningococcal infections can lead to severe, sometimes deadly, bloodstream infections, and severe swelling in the brain and spinal cord.

15 Feb 2025 - 10:25PM

Medicine

WHO recommends malaria vaccine for children, to be rolled out next year

The vaccine, developed in the UK, will become available to countries by mid-2024 and doses will cost between US$2 and US$4, said WHO chief Tedros Adhanom Ghebreyesus on Monday.

3 Oct 2023 - 2:27AMvideocam

Coronavirus pandemic

This man says he can beat Covid-19 with nasal sprays, not needles

Marty Moore, founder of Meissa Vaccines, says nasal sprays could be the future of the fight against Covid-19 and its variants by building better protection where the battle begins.

4 Jun 2022 - 5:39AM

Coronavirus pandemic